IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN CLONE ACZ885 HEAVY CHAIN V REGION)
Cryopyrin-associated Periodic Syndromes (CAPS)
Novartis Pharmaceuticalsmonoclonal_antibodyActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Cryopyrin-associated Periodic Syndromes (CAPS) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
EVUZAMITIDE National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | CC |
Same molecule, other indications
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN CLONE ACZ885 HEAVY CHAIN V REGION) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →